Monitor the identified social media channels and the company's website for future material disclosures, as the company may use these channels for first disclosure of material information.
REVB drugs
REVB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $4.27entry
- T+1 · 19h ago −10.43%α −8.52% · $3.82
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Revelation Biosciences filed an 8-K to disclose its intention to use social media channels (X, Facebook, Instagram, Threads, LinkedIn, TikTok, YouTube, Discord, Reddit) and its corporate website landing page for communicating material information under Regulation FD. The filing is a routine disclosure channels update with no financial data or material events.
Key Facts
- Company identified 9 social media channels for material disclosures under Regulation FD.
- Corporate website landing page (www.revbiosciences.com) will host social media disclosures.
- No financial data, guidance, preliminary results, or material agreements were disclosed.
- Market cap is $3M with a normal daily move of 10.5%.
Financial Impact
No financial impact; administrative disclosure only.
Risk Factors
- Social media posts may contain forward-looking statements subject to risks and uncertainties.
- Investors must monitor multiple channels to stay informed of material disclosures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-460055 |
| Document: 0001193125-26-460055-index.html | 0001193125-26-460055 |
| Document: 0001193125-26-460055.txt | 0001193125-26-460055 |
Track record
4 reports on REVB
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago 8-K Neutral 2/10 Viewing Entry $4.27 Now $3.82 −10.43% settles Nov 20
- Nov 5, 202611d ago 8-K Bearish 4/10 Entry $3.89 to $4.27 Now $3.82 +1.80% ▼ −9.64% −7.05% vs SPY
- Aug 19, 202612w ago 8-K Neutral 3/10 Entry $1.07 to $1.03 Now $3.82 +257.01% ▼ −3.74% −4.85% vs SPY
- Jun 24, 202620w ago 8-K Neutral 4/10 Entry $0.9600 to $1.04 Now $3.82 +297.92% ▲ +8.33% +6.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers